Annual Operating Expenses
$38.26 M
+$7.70 M+25.20%
December 31, 2022
Summary
- As of February 10, 2025, BTTX annual total operating expenses is $38.26 million, with the most recent change of +$7.70 million (+25.20%) on December 31, 2022.
- During the last 3 years, BTTX annual operating expenses has risen by +$33.37 million (+681.97%).
- BTTX annual operating expenses is now at all-time high.
Performance
BTTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$5.34 M
-$1.68 M-23.97%
September 30, 2023
Summary
- As of February 10, 2025, BTTX quarterly total operating expenses is $5.34 million, with the most recent change of -$1.68 million (-23.97%) on September 30, 2023.
- Over the past year, BTTX quarterly operating expenses has dropped by -$5.66 million (-51.43%).
- BTTX quarterly operating expenses is now -55.87% below its all-time high of $12.10 million, reached on December 31, 2021.
Performance
BTTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BTTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.2% | -51.4% |
| 3 y3 years | +682.0% | +78.8% |
| 5 y5 years | +682.0% | +518.2% |
BTTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.2% | -55.9% | at low |
| 5 y | 5-year | at high | +682.0% | -55.9% | +518.2% |
| alltime | all time | at high | +682.0% | -55.9% | +518.2% |
Better Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $5.34 M(-24.0%) |
| Jun 2023 | - | $7.03 M(-21.3%) |
| Mar 2023 | - | $8.93 M(+7.2%) |
| Dec 2022 | $38.26 M(+25.2%) | $8.32 M(-24.3%) |
| Sep 2022 | - | $11.00 M(+14.6%) |
| Jun 2022 | - | $9.60 M(+2.7%) |
| Mar 2022 | - | $9.35 M(-22.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $30.56 M(+382.7%) | $12.10 M(+34.6%) |
| Sep 2021 | - | $8.99 M(+38.9%) |
| Jun 2021 | - | $6.47 M(+116.7%) |
| Mar 2021 | - | $2.99 M(+245.7%) |
| Dec 2020 | $6.33 M(+29.4%) | - |
| Jun 2020 | - | $864.00 K |
| Dec 2019 | $4.89 M | - |
FAQ
- What is Better Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Better Therapeutics?
- What is Better Therapeutics annual operating expenses year-on-year change?
- What is Better Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Better Therapeutics?
- What is Better Therapeutics quarterly operating expenses year-on-year change?
What is Better Therapeutics annual total operating expenses?
The current annual operating expenses of BTTX is $38.26 M
What is the all time high annual operating expenses for Better Therapeutics?
Better Therapeutics all-time high annual total operating expenses is $38.26 M
What is Better Therapeutics annual operating expenses year-on-year change?
Over the past year, BTTX annual total operating expenses has changed by +$7.70 M (+25.20%)
What is Better Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of BTTX is $5.34 M
What is the all time high quarterly operating expenses for Better Therapeutics?
Better Therapeutics all-time high quarterly total operating expenses is $12.10 M
What is Better Therapeutics quarterly operating expenses year-on-year change?
Over the past year, BTTX quarterly total operating expenses has changed by -$5.66 M (-51.43%)